Vitranu develops novel extended administration drug delivery technology.
Vitranu has raised $1.5M in total funding. The most recent round was Debt Financing. The last funding was announced in October 2021.
Vitranu is headquartered in Columbus, United States.
Vitranu develops novel extended administration drug delivery technology.
Vitranu is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vitranu — Funding & Investors." VCBacked, October 25, 2021, https://www.vcbacked.co/company/vitranu. Accessed August 14, 2026.
VCBacked. (2021). Vitranu — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vitranu
{{cite web |title=Vitranu — Funding & Investors |url=https://www.vcbacked.co/company/vitranu |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated